Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors: A cross-sectional study of cancer survivors.
Breast Neoplasms
/ psychology
Cancer Survivors
/ psychology
Colorectal Neoplasms
/ psychology
Cross-Sectional Studies
Fear
/ psychology
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
/ epidemiology
Prevalence
Prospective Studies
Quality of Life
Retrospective Studies
Surveys and Questionnaires
breast cancer
cancer survivors
colorectal cancer
fear of cancer recurrence
survivorship
Journal
Asia-Pacific journal of clinical oncology
ISSN: 1743-7563
Titre abrégé: Asia Pac J Clin Oncol
Pays: Australia
ID NLM: 101241430
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
17
03
2020
accepted:
26
06
2020
pubmed:
21
10
2020
medline:
29
6
2021
entrez:
20
10
2020
Statut:
ppublish
Résumé
To define the prevalence and severity of fear of cancer recurrence and identify factors associated with fear of cancer recurrence in breast cancer and colorectal cancer survivors attending the Sydney Cancer Survivorship Clinic. A cross-sectional study was performed using prospectively collected data. Survivors completed questionnaires assessing quality of life (Functional Assessment of Cancer Therapy-General and symptoms (Distress Thermometer, Patient's Disease and Treatment Assessment Form)). Survivors were assessed by a clinical psychologist for the presence of fear of cancer recurrence. Clinical and quality of life variables were evaluated for associations with fear of cancer recurrence. Overall, 315 survivors (181 breast cancer, 134 colorectal cancer) were included. In total, 201 survivors (64%) had fear of cancer recurrence according to psychology assessment, and of the 118 that had fear of cancer recurrence severity recorded, 64 (54%) were rated as moderate-severe. On univariate analysis, fear of cancer recurrence was associated with younger age (P < 0.001), higher distress thermometer score (P = 0.001) and poorer overall wellbeing (P < 0.001). On multivariate analysis, younger age (P = 0.043), being bothered by side effects of treatment (P = 0.023), feeling sad (P = 0.020) and greater worry that their condition will get worse (P = 0.017) were independently associated with fear of cancer recurrence. Fear of cancer recurrence is common in breast and colorectal cancer survivors, and moderate-severe in over half. Fear of cancer recurrence was independently associated with younger age, feeling sad, being more bothered by side effects.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
222-229Informations de copyright
© 2020 John Wiley & Sons Australia, Ltd.
Références
Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: Definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265-3268.
Koch L, Bertram H, Eberle A, et al. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship-A multi-regional population-based study. Psychooncology. 2014;23(5):547-554.
Butow PN, Fardell JE, Smith A. Fear of Cancer Recurrence: An overview and Australian perspective. CancerForum. 2015;39(2):95-100.
Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300-322.
Hodges LJ, Humphris GM. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology. 2009;18(8):841-848.
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psychooncology. 2013;22(5):978-986.
Yang Y, Wen Y, Bedi C, Humphris G. The relationship between cancer patient's fear of recurrence and chemotherapy: A systematic review and meta-analysis. J Psychosom Res. 2017;98:55-63.
Yang Y, Cameron J, Humphris G. The relationship between cancer patient's fear of recurrence and radiotherapy: A systematic review and meta-analysis. Psychooncology. 2017;26(6):738-746.
Sharpe L, Curran L, Butow P, Thewes B. Fear of cancer recurrence and death anxiety. Psychooncology. 2018;27(11):2559-2565.
Maheu C, Hébert M, Louli J, et al. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer. Cancer Reports. 2019;2(4):e1172.
Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213-220.
Vickberg SM. The Concerns About Recurrence Scale (CARS): A systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16-24.
Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases: Psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505-511.
Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241-251.
Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9(3):481-491.
Mutsaers B, Butow P, Dinkel A, et al. Identifying the key characteristics of clinical fear of cancer recurrence: An international Delphi study. Psychooncology. 2019;;29(2):430-436.
Fardell JE, Jones G, Smith AB, et al. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence. Psychooncology. 2018;27(2):492-499.
Vardy JL, Tan C, Turner JD, Dhillon H. Health status and needs of cancer survivors attending the Sydney Survivorship Centre clinics and programmes: A protocol for longitudinal evaluation of the centre's services. BMJ Open. 2017;7(5):e014803.
Tan SY, Turner J, Kerin-Ayres K, et al. Health concerns of cancer survivors after primary anti-cancer treatment. Support Care Cancer. 2019;27(10):3739-3747.
Gessler S, Low J, Daniells E, et al. Screening for distress in cancer patients: Is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psychooncology. 2008;17(6):538-547.
Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw. 2010;8(4):448-485.
Stockler MR, O'Connell R, Nowak AK, et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: A placebo-controlled double-blind randomised trial. Lancet Oncol. 2007;8(7):603-612.
Coates A, Glasziou P, McNeil D. On the receiving end-III. Measurement of quality of life during cancer chemotherapy. Ann Oncol. 1990;1(3):213-217.
FACIT.org. Questionnaires 2020 [Available from: https://www.facit.org/FACITOrg/Questionnaires.
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol. 1993;11(3):570-579.
Butow PN, Turner J, Gilchrist J, et al. Randomized Trial of Conquer Fear: A novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol. 2017;35(36):4066-4077.
Niu L, Liang Y, Niu M. Factors influencing fear of cancer recurrence in patients with breast cancer: Evidence from a survey in Yancheng, China. J Obstet Gynaecol Res. 2019;45(7):1319-1327.
Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG. Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: Findings from a nationally representative sample. J Psychosoc Oncol. 2020;38(2):125-142.
van de Wal M, van de Poll-Franse L, Prins J, Gielissen M. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. Psychooncology. 2016;25(7):772-778.
Tauber NM, O'Toole MS, Dinkel A, et al. Effect of psychological intervention on Fear of Cancer Recurrence: A systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899-2915.
Butow P, Shaw J, Vaccaro L, et al. A research agenda for fear of cancer recurrence: A Delphi study conducted in Australia. Psychooncology. 2019;28(5):989-996.